ES2233805T3 - Modifcacion cristalina de un depsipetido ciclico con avtividad mejorada. - Google Patents

Modifcacion cristalina de un depsipetido ciclico con avtividad mejorada.

Info

Publication number
ES2233805T3
ES2233805T3 ES02716073T ES02716073T ES2233805T3 ES 2233805 T3 ES2233805 T3 ES 2233805T3 ES 02716073 T ES02716073 T ES 02716073T ES 02716073 T ES02716073 T ES 02716073T ES 2233805 T3 ES2233805 T3 ES 2233805T3
Authority
ES
Spain
Prior art keywords
spp
modification
animals
cyclic
depsipetide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02716073T
Other languages
English (en)
Spanish (es)
Inventor
Jochen Kalbe
Michael Traeubel
Achim Harder
Georg Von Samson-Himmelstjerna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Application granted granted Critical
Publication of ES2233805T3 publication Critical patent/ES2233805T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES02716073T 2001-02-01 2002-01-21 Modifcacion cristalina de un depsipetido ciclico con avtividad mejorada. Expired - Lifetime ES2233805T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104362 2001-02-01
DE10104362A DE10104362A1 (de) 2001-02-01 2001-02-01 Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit

Publications (1)

Publication Number Publication Date
ES2233805T3 true ES2233805T3 (es) 2005-06-16

Family

ID=7672376

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02716073T Expired - Lifetime ES2233805T3 (es) 2001-02-01 2002-01-21 Modifcacion cristalina de un depsipetido ciclico con avtividad mejorada.

Country Status (27)

Country Link
US (1) US20040115483A1 (enExample)
EP (1) EP1357932B1 (enExample)
JP (1) JP2004525111A (enExample)
KR (2) KR20030081378A (enExample)
CN (1) CN1278735C (enExample)
AT (1) ATE284703T1 (enExample)
AU (1) AU2002226415B2 (enExample)
BR (1) BRPI0206841B8 (enExample)
CA (1) CA2436832C (enExample)
CR (1) CR7039A (enExample)
CZ (1) CZ299564B6 (enExample)
DE (2) DE10104362A1 (enExample)
EE (1) EE05490B1 (enExample)
ES (1) ES2233805T3 (enExample)
HR (1) HRP20030635A2 (enExample)
HU (1) HU229229B1 (enExample)
IL (2) IL157026A0 (enExample)
MX (1) MXPA03006866A (enExample)
NO (1) NO331289B1 (enExample)
NZ (1) NZ527230A (enExample)
PL (1) PL213106B1 (enExample)
PT (1) PT1357932E (enExample)
RU (1) RU2300390C2 (enExample)
SK (1) SK286280B6 (enExample)
UA (1) UA74623C2 (enExample)
WO (1) WO2002066048A1 (enExample)
ZA (1) ZA200305864B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080003546A1 (en) * 2006-06-29 2008-01-03 Dunbar Kimberly L Animated digital charted yarncraft instruction
RS62130B1 (sr) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
EP3397638B1 (en) 2015-12-28 2023-08-23 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
CN114262303A (zh) * 2022-01-04 2022-04-01 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型ii及其制备方法
CN114195732A (zh) * 2022-01-04 2022-03-18 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型iii及其制备方法
CN115010680A (zh) * 2022-07-13 2022-09-06 丽珠集团福州福兴医药有限公司 单晶型i的艾默德斯及其制备方法
CN114989110A (zh) * 2022-07-13 2022-09-02 丽珠集团福州福兴医药有限公司 单晶型ⅳ的艾默德斯及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2096907A (en) * 1981-04-22 1982-10-27 Exxon Research Engineering Co Distillation column with steam stripping
DK0634408T3 (da) * 1992-03-17 2002-04-22 Fujisawa Pharmaceutical Co Depsipeptidderivater, fremstilling og anvendelse deraf
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
EP0872481B1 (en) * 1995-06-30 2009-03-18 Astellas Pharma Inc. Depsipeptide derivative, process for production thereof, and novel intermediate therefor
DE69634961T2 (de) * 1995-09-22 2006-04-20 Bayer Ag Neue zyklische depsipeptid pf1022 derivate
KR100551651B1 (ko) * 1997-11-10 2006-02-13 아스텔라스세이야쿠 가부시키가이샤 뎁시펩티드 유도체의 신규 결정 및 그의 제조 방법
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere

Also Published As

Publication number Publication date
PL213106B1 (pl) 2013-01-31
HUP0302880A2 (hu) 2003-12-29
NO20033413D0 (no) 2003-07-30
NZ527230A (en) 2005-04-29
BR0206841A (pt) 2004-02-25
BRPI0206841B1 (pt) 2018-02-14
RU2003126589A (ru) 2005-02-27
HUP0302880A3 (en) 2005-05-30
CZ20032063A3 (cs) 2003-11-12
EE05490B1 (et) 2011-12-15
AU2002226415B2 (en) 2007-03-22
HRP20030635A2 (en) 2005-10-31
CA2436832C (en) 2013-06-11
CN1592631A (zh) 2005-03-09
SK286280B6 (sk) 2008-06-06
KR20090041451A (ko) 2009-04-28
DE50201777D1 (de) 2005-01-20
CA2436832A1 (en) 2002-08-29
PL362389A1 (en) 2004-11-02
US20040115483A1 (en) 2004-06-17
MXPA03006866A (es) 2004-05-31
PT1357932E (pt) 2005-04-29
EP1357932B1 (de) 2004-12-15
WO2002066048A8 (de) 2003-11-20
IL157026A (en) 2010-11-30
BRPI0206841B8 (pt) 2021-05-25
HK1075013A1 (en) 2005-12-02
IL157026A0 (en) 2004-02-08
WO2002066048A1 (de) 2002-08-29
DE10104362A1 (de) 2002-08-08
NO20033413L (no) 2003-09-26
KR20030081378A (ko) 2003-10-17
ATE284703T1 (de) 2005-01-15
CN1278735C (zh) 2006-10-11
CR7039A (es) 2004-06-08
SK9882003A3 (en) 2003-12-02
EP1357932A1 (de) 2003-11-05
RU2300390C2 (ru) 2007-06-10
ZA200305864B (en) 2004-08-27
HU229229B1 (en) 2013-09-30
NO331289B1 (no) 2011-11-21
EE200300365A (et) 2003-10-15
CZ299564B6 (cs) 2008-09-03
UA74623C2 (en) 2006-01-16
JP2004525111A (ja) 2004-08-19

Similar Documents

Publication Publication Date Title
JP4104653B2 (ja) 殺内部寄生虫組成物
EP0662326B1 (de) Endoparasitizide Mittel die Praziquantel und Epsiprantel enthalten
US5036069A (en) Anthelmintic active compound combinations
RU2548733C2 (ru) Твердое лекарственное средство с замедленным высвобождением действующих веществ
KR100372348B1 (ko) 내부기생충구제를위한곤충의니코틴효능성아세틸콜린수용체에대한길항물질및효능물질
CA2400610C (en) Endoparasiticidal compositions comprising a cyclic depsipeptide
RU2300390C2 (ru) Кристаллическая модификация циклического депсипептида с улучшенной активностью
JP4202422B2 (ja) ヘキサヒドロピラジン誘導体の経口投与できる顆粒剤
RU2250779C2 (ru) Эндопаразитицидное средство
HUP0102476A2 (hu) Szubsztituált ciklooktadepszipeptidek
MXPA00011972A (en) Substituted cyclooctadepsipeptides